Drug Trial Radar · NCT06832540
Mass Balance Study of [14C] TJ0113 in Healthy Chinese Subjects
Last checked: Nov 19, 2026Latest source record: Nov 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
6
Actual
Start
Feb 19, 2025
Primary completion
Mar 5, 2025
Study completion Mar 5, 2025
Sponsor
- Lead sponsor
- Hangzhou PhecdaMed Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Feb 18, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Mass Balance Study of \[14C\] TJ0113 in Healthy Chinese Subjects
Conditions
- Healthy Chinese Subjects
Interventions
[14C]TJ0113Drug
Subjects will receive a single oral dose of approximately 200 mg/100 μCi of the oral formulation of \[14C\] TJ0113 under fasted conditions.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The excretion ratio of total radioactivity at each time interval and the cumulative recovery of total radioactivity in urine and fecesTime frame: Predose up to 240 hours after administration of [14C]TJ0113
- Pharmacokinetic parameters of total radioactivity in plasma: CmaxTime frame: Predose up to 168 hours after administration of [14C]TJ0113
- Pharmacokinetic parameters of total radioactivity in plasma: TmaxTime frame: Predose up to 168 hours after administration of [14C]TJ0113
- Pharmacokinetic parameters of total radioactivity in plasma: t1/2Time frame: Predose up to 168 hours after administration of [14C]TJ0113
- Pharmacokinetic parameters of total radioactivity in plasma: MRTTime frame: Predose up to 168 hours after administration of [14C]TJ0113
- Pharmacokinetic parameters of total radioactivity in plasma: AUCTime frame: Predose up to 168 hours after administration of [14C]TJ0113
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Affiliated Hospital of Jiangnan University
Wuxi, Jiangsu, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.